Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 320

1.

Ovulation induction and in vitro fertilization in systemic lupus erythematosus and antiphospholipid syndrome.

Guballa N, Sammaritano L, Schwartzman S, Buyon J, Lockshin MD.

Arthritis Rheum. 2000 Mar;43(3):550-6.

2.

Importance of planning ovulation induction therapy in systemic lupus erythematosus and antiphospholipid syndrome: a single center retrospective study of 21 cases and 114 cycles.

Huong DL, Wechsler B, Vauthier-Brouzes D, Duhaut P, Costedoat N, Lefebvre G, Piette JC.

Semin Arthritis Rheum. 2002 Dec;32(3):174-88.

PMID:
12528082
3.

Ovarian stimulation for ovulation induction and in vitro fertilization in patients with systemic lupus erythematosus and antiphospholipid syndrome.

Bellver J, Pellicer A.

Fertil Steril. 2009 Dec;92(6):1803-10. doi: 10.1016/j.fertnstert.2009.06.033. Epub 2009 Jul 25. Review.

PMID:
19632675
4.

Determinants of risk for venous and arterial thrombosis in primary antiphospholipid syndrome and in antiphospholipid syndrome with systemic lupus erythematosus.

Danowski A, de Azevedo MN, de Souza Papi JA, Petri M.

J Rheumatol. 2009 Jun;36(6):1195-9. doi: 10.3899/jrheum.081194. Epub 2009 May 15.

PMID:
19447935
5.

[Ovulation induction therapy and systemic lupus erythematosus].

Lê Thi Huong D, Wechsler B, Piette JC.

Ann Med Interne (Paris). 2003 Feb;154(1):45-50. Review. French.

PMID:
12746658
6.

Longitudinal study of antinuclear and anticardiolipin antibodies in pregnant women with systemic lupus erythematosus and antiphospholipid syndrome.

Salazar-Páramo M, Jara LJ, Ramos A, Barile L, Machado G, García-De La Torre I.

Rheumatol Int. 2002 Aug;22(4):142-7. Epub 2002 Jun 19.

PMID:
12172952
7.

The value of IgA antiphospholipid testing for diagnosis of antiphospholipid (Hughes) syndrome in systemic lupus erythematosus.

Bertolaccini ML, Atsumi T, Escudero Contreras A, Khamashta MA, Hughes GR.

J Rheumatol. 2001 Dec;28(12):2637-43.

PMID:
11764209
8.

Risks of ovulation-induction therapy in systemic lupus erythematosus.

Huong DL, Wechsler B, Piette JC, Arfi S, Gallinari C, Darbois Y, Frances C, Godeau P.

Br J Rheumatol. 1996 Nov;35(11):1184-6.

9.
10.

[In vitro fertilization and systemic lupus erythematosus or antiphospholipid syndrome: An update].

Orquevaux P, Masseau A, Le Guern V, Gayet V, Vauthier D, Boutin D, Wechsler B, Morel N, Guettrot-Imbert G, Pennaforte JL, Piette JC, Costedoat-Chalumeau N.

Rev Med Interne. 2015 Mar;36(3):154-8. doi: 10.1016/j.revmed.2014.08.004. Epub 2014 Sep 10. Review. French.

PMID:
25217451
11.

Long-term follow-up in 128 patients with primary antiphospholipid syndrome: do they develop lupus?

Gómez-Puerta JA, Martín H, Amigo MC, Aguirre MA, Camps MT, Cuadrado MJ, Hughes GR, Khamashta MA.

Medicine (Baltimore). 2005 Jul;84(4):225-30.

12.

Late ovarian hyperstimulation syndrome after controlled ovarian stimulation in a woman with systemic lupus erythematosus and lupus nephritis.

Crochet JR, Yeh JS, Clowse ME, Copland SD.

Fertil Steril. 2011 Apr;95(5):1786.e13-6. doi: 10.1016/j.fertnstert.2010.11.016. Epub 2010 Dec 18.

PMID:
21168129
13.

Prevalence and clinical significance of antiprothrombin antibodies in patients with systemic lupus erythematosus or with primary antiphospholipid syndrome.

Muñoz-Rodríguez FJ, Reverter JC, Font J, Tàssies D, Cervera R, Espinosa G, Carmona F, Balasch J, Ordinas A, Ingelmo M.

Haematologica. 2000 Jun;85(6):632-7.

14.

The HELLP syndrome in the antiphospholipid syndrome: retrospective study of 16 cases in 15 women.

Le Thi Thuong D, Tieulié N, Costedoat N, Andreu MR, Wechsler B, Vauthier-Brouzes D, Aumaître O, Piette JC.

Ann Rheum Dis. 2005 Feb;64(2):273-8. Review.

15.

Primary antiphospholipid syndrome as the forerunner of systemic lupus erythematosus.

Tarr T, Lakos G, Bhattoa HP, Szegedi G, Shoenfeld Y, Kiss E.

Lupus. 2007;16(5):324-8.

PMID:
17576733
16.
17.

How to manage patients with systemic lupus erythematosus who are also antiphospholipid antibody positive.

Giles I, Rahman A.

Best Pract Res Clin Rheumatol. 2009 Aug;23(4):525-37. doi: 10.1016/j.berh.2009.01.009.

PMID:
19591782
19.

Preclinical vascular disease in systemic lupus erythematosus and primary antiphospholipid syndrome.

Jiménez S, García-Criado MA, Tàssies D, Reverter JC, Cervera R, Gilabert MR, Zambón D, Ros E, Bru C, Font J.

Rheumatology (Oxford). 2005 Jun;44(6):756-61. Epub 2005 Mar 9.

20.

Antiphospholipid syndrome nephropathy in patients with systemic lupus erythematosus and antiphospholipid antibodies: prevalence, clinical associations, and long-term outcome.

Tektonidou MG, Sotsiou F, Nakopoulou L, Vlachoyiannopoulos PG, Moutsopoulos HM.

Arthritis Rheum. 2004 Aug;50(8):2569-79.

Items per page

Supplemental Content

Write to the Help Desk